New test capable of detecting clinically significant prostate cancer in small blood sample Bangkok/Basel, August 2019 (via PR Newswire) – An international research team at Mahidol University in Bangkok, Thailand, has demonstrated the potential for a new blood test to...
X-ZELL to launch AI-powered cell analysis project Singapore, July 2019 – Singapore-based rare cell detection specialist, X-ZELL, is about to embark on the most ambitious research and innovation project in the company’s history. Nicknamed Cloud Atlas, the landmark...
Episode 12 Why building on tradition is key to a future without cancer Two years ago, almost to the day, X-ZELL hit a milestone that many say separates the wheat from the chaff – the equally daunting and exhilarating leap from research to commercialisation. Under the...
Episode 11 Why Singapore is Asia’s leading med tech hub Artificial intelligence, 3D printing, driverless transportation – the innovation wheel has never spun as fast as today. Despite the much-cited Theranos effect – coined by Bloomberg to describe the painful...
X-ZELL global HQ now open for business in Singapore Singapore, May 2019 – X-ZELL, only recently named one of Asia’s 20 most innovative health tech start-ups, today opened its new global headquarters at Paya Lebar Square in Singapore, conveniently located between...
